Novartis, the Swiss pharmaceutical giant that owns Alcon, is buying Encore Vision, a Fort Worth startup that has developed a drug to treat presbyopia. Novartis said Tuesday that the acquisition would add a “first-in-class” treatment to its ophthalmology pipeline, “providing